Research Publication Demonstrates Utility of Applied DNA’s LinearDNA™ in Non-Viral CAR T Manufacturing
November 9th, 2021
Tag: CAR T
Applied DNA Announces Linear DNA Orders from New Contract Research Customers for Use in RNA Vaccine and Adeno-Associated Virus Applications
November 2nd, 2020
Applied DNA Ships LinearDNA™ to Another Development Customer
March 26th, 2020
APDN Secures Top-20 Pharmaceutical Manufacturer as Drug Development Customer
March 20th, 2020
Medicare Coverage of CAR T-Cell Therapy Holds Positive Implications for LineaRx
August 12th, 2019
LineaRx Achieves Anti-CD19 Expression in Human CAR T Cells via Plasmid-Free Platform
April 8th, 2019
LineaRx to Announce DNA Vaccine Preclinical Data and Efficacy of In-Licensed CAR T Therapy
December 4th, 2018
At LineaRX, Putting The Horsepower Behind The CAR T
October 17th, 2018
Plasmid-Free CAR T-Manufacturing Platform Begins Preclinicals
October 16th, 2018